Benzinga's Top Initiations
March 03, 2015 at 09:07 AM EST
Analysts at Brean Capital initiated coverage on Syneron Medical Ltd. (NASDAQ: ELOS) with a Buy rating. The target price for Syneron ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.